News

Sylogist Ltd (SYZLF) reports significant recurring revenue growth and robust bookings, despite facing challenges in margin compression and project services revenue decline.
Q2 2025 Earnings Call Transcript August 14, 2025Brainstorm Cell Therapeutics Inc. beats earnings expectations.
Achieves Strong Financial Performance; Continuing To Deliver Shareholder Value VANCOUVER, BC / ACCESS Newswire / August 13, ...
Aumann AG (AUUMF) demonstrates resilience with a solid financial foundation and strategic growth beyond automotive, despite revenue and order intake declines.